Personalized Medicine and Companion Diagnostic Development
Pharmaceutical and biotech companies are putting tremendous effort in the research of the discovery and management of biomarkers; however, there is a lot to be done on the qualification, validation and applications of the biomarkers.
In this complimentary webinar, Dr. Austin Tanney discusses Almac Diagnostic's ability to provide enabling technology in IXRS and DSA research tools.
This webinar highlights:
- How to aid in design of a suitable trial for biomarker development
- Collect real time data
- The ability to design and support dynamic randomization
- Companion diagnostic development
- Efficiency to manage medication in the ATD setting
- Trial design for biomarker discovery
Presenters: